SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: CARYTRE who wrote (1159)1/16/1998 8:51:00 AM
From: Frank Buck  Read Replies (1) of 1894
 
Cary,

All your points are well taken, but #5 in particular is very important. 5) Retaining manfacturing sounds like a big plus too. Since there should be built in profit margin there, for 100% of the goods. More efficient capital utilization leads to higher return on equity.

AccuMed should realize escalating margin capabilities with an increasingly higher number of units manufactured and sold; margin of scale.

Was #6, corn(y) seeds you were sowing? I thought I was the only one that planted that particular kernel. Thanks for joining me. Must be a writing characteristic of us midwesterners.<G>

Frank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext